First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM
Julien Bador1, Lucie Amoureux, Jean-Marie Duez
1Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon Cedex, France.
Abstract:
Achromobacter xylosoxidans is an emerging pathogen in cystic fibrosis patients. The multidrug resistance of these bacteria remains poorly understood. We have characterized in a clinical strain the first resistance-nodulation-cell division (RND)-type multidrug efflux pump in this species: AxyABM. The inactivation of the transporter component axyB gene led to decreased MICs of cephalosporins (except cefepime), aztreonam, nalidixic acid, fluoroquinolones, and chloramphenicol.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antibiotic Selection
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Clinical Significance of Antibiotic Resistance


